BRD9876 is an ATP non-competitive and Mitotic Kinesin-5 (Eg5) Inhibitor
Multiple myeloma cells have greater phosphorylated Eg5 than hematopoietic cells. Eg5 phosphorylation increases microtubule binding and uniquely enhances BRD9876 activity. BRD9876 acts as an ATP- and ADP-competitive inhibitor with a…